largest client
“10-K Item 1A: 'Our two largest clients accounted for approximately 29.2% and 10.4%, respectively, of our revenues for the year ended December 31, 2025.'”
Updated
The most significant concentration Claritev discloses is largest client at 29.2%, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Claritev’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1A: 'Our two largest clients accounted for approximately 29.2% and 10.4%, respectively, of our revenues for the year ended December 31, 2025.'”
“10-K Item 1A: 'Our two largest clients accounted for approximately 29.2% and 10.4%, respectively, of our revenues for the year ended December 31, 2025.'”
Claritev's concentration risk is client-based, with two customers accounting for a meaningful share of revenue at different scales. The two largest clients accounted for approximately 29.2% and 10.4% of revenues for the year ended December 31, 2025, respectively — the largest representing a moderate share and the second a more modest one. Both are dependency-type exposures tied to specific counterparty relationships rather than structural features of the business. Combined, the top two clients account for roughly two-fifths of revenue, meaning a disruption to either relationship — particularly the largest, given its meaningfully larger share — could have a material effect on results. The gap between the two clients' shares also matters: the largest client alone carries nearly three times the revenue share of the second, so the concentration is not evenly distributed but rather weighted heavily toward retaining a single relationship. This makes the largest client the exposure most likely to move the verdict, while the second client represents a real but comparatively smaller dependency.
For the engine’s reasoning on CTEV’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | 1 | 0 | 0 | 1 |
| BTSG | BrightSpring Health Services, I | 0 | 2 | 0 | 2 |
| EVH | Evolent Health, Inc | 0 | 1 | 3 | 4 |
| CTEV● | Claritev Corporation | 0 | 1 | 1 | 2 |
| DOCS | Doximity, Inc. | 0 | 1 | 1 | 2 |
| CERT | Certara, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.